Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
Sep 9, 2021
Odyssey Group International Approved to Start Human Trial to Treat Concussion
Sep 1, 2021
Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch
Aug 30, 2021
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
Aug 6, 2021
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
Aug 4, 2021
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield”  to Discuss Concussion Treatments
Jul 27, 2021
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
Jul 26, 2021
Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion
Jun 29, 2021
Odyssey Group International to Present at LD Micro Virtual Investor Conference
Jun 8, 2021
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
Jun 2, 2021